Skip to main content
Log in

Biodistribution of immunoliposome labeled with Tc-99m in tumor xenografted mice

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Immunoliposome (PEG, GAH, liposome; PGL), consisting of F(ab′)2 fragment of monoclonal antibody, GAH and polyethyleneglycol-coated (PEGylated) liposome was provided. Immunoliposome, PGL was labeled with technetium-99m (Tc-99m) by two methods: labeling F(ab′)2 fragment with Tc-99m; Tc-99m-PGL, and entrapping Tc-99m into liposome; PGL[Tc-99m]. The objective of this study was to compare the biodistribution of Tc-99m-PGL and PGL[Tc-99m] in human gastric cancer xenografted mice.

Methods

Tc-99m-PGL, PGL[Tc-99m], and Tc-99m-entrapped liposome; Lipo[Tc-99m] were prepared. They were injected into human gastric cancer, MKN45, xenografted mice via the tail vein, and their biodistribution was studied.

Results

No marked accumulation of either PGL[Tc-99m] or Lipo[Tc-99m] was observed in the stomach. The uptake of Tc-99m-PGL by the liver, spleen, and lung was higher than that by the tumor. On the other hand, the uptake of PGL[Tc-99m] by the lung and spleen was markedly lower as compared with that of Tc-99m-PGL; the accumulation of PGL[Tc-99m] was lower in the lung and higher in the spleen as compared with that of the tumor. Although the liver uptake of PGL[Tc-99m] was markedly decreased as compared with that of Tc-99m-PGL, it was higher than the uptake of the tumor. The Tc-99m-PGL was strongly taken up by the tumor, with a high level of incorporation also seen in the stomach. These findings suggest the need for further study of the labeling stability.

Conclusions

PGL[Tc-99m] appears to show promise for high tumor uptake and retention. This is an important implication for the potential application of immunoliposomes entrapped with Re-186, instead of Tc-99m, in internal radiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hamoudeh M, Kamleh MA, Diab R, Fessi H. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv Drug Deliv Rev 2008;60:1329–1346. [Epub 2008 Apr 30].

    Article  PubMed  CAS  Google Scholar 

  2. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991;1066:29–36.

    Article  PubMed  CAS  Google Scholar 

  3. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1991;1062:77–82.

    Article  PubMed  CAS  Google Scholar 

  4. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991;88:11460–11464.

    Article  PubMed  CAS  Google Scholar 

  5. Hashimoto Y, Sugawara M, Masuko T, Hojo H. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody. Cancer Res 1983;43:5328–5334.

    PubMed  CAS  Google Scholar 

  6. Benz CC, Martin FJ. Future directions of liposome- and immunoliposome-based cancer therapeutics. Semin Oncol. 2004;31(Suppl 13):196–205.

    PubMed  Google Scholar 

  7. Torchilin V. Antibody-modified liposomes for cancer chemotherapy. Expert Opin Drug Deliv 2008;5:1003–1025.

    Article  PubMed  CAS  Google Scholar 

  8. Hamoudeh M, Kamleh MA, Diab R, Fessi H. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv Drug Deliv Rev 2008;60:1329–1346.

    Article  PubMed  CAS  Google Scholar 

  9. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962;194:495–496.

    Article  PubMed  CAS  Google Scholar 

  10. Hansen HJ, Jones AL, Grebenau R, Kunz A, Goldenberg DM. Labeling of anti-tumor antibodies and antibody fragments with Tc-99m. Cancer Treat Res 1990;51:233–244.

    PubMed  CAS  Google Scholar 

  11. Goins B, Klipper R, Rudolph AS, Cliff RO, Blumhardt R, Phillips WT. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J Nucl Med 1993;34:2160–2168.

    PubMed  CAS  Google Scholar 

  12. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Hain RK. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor zenograft. Cancer Res 1994;54:3352–3356.

    PubMed  CAS  Google Scholar 

  13. Klibanov A, Huang L. Long-circulating liposomes: Developing and perspectives. J Liposomes Res 1991;2:321–324.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoto Kitamura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kitamura, N., Shigematsu, N., Nakahara, T. et al. Biodistribution of immunoliposome labeled with Tc-99m in tumor xenografted mice. Ann Nucl Med 23, 149–153 (2009). https://doi.org/10.1007/s12149-008-0222-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-008-0222-4

Keywords

Navigation